Medprin Medical's Dural Sealant Product Enters Special Review Pathway for Innovative Medical Devices

Stock News

Apr 15

Medprin Regenerative Medical Technologies Co.,Ltd. (301033.SZ) announced that its self-developed dural sealant product has recently been accepted by the Center for Medical Device Evaluation of the National Medical Products Administration to enter the special review program for innovative medical devices. The dural sealant is indicated for assisting in the closure of dural suture sites to prevent cerebrospinal fluid leakage. Based on an electrophile-nucleophile reaction mechanism, the product utilizes a globally leading patented technical formula and auxiliary accessories to achieve immediate and efficient sealing of dural suture sites during surgical procedures.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1194456333"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194456333\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194456333?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-15 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194456333","market":"hk","top_or_hot":-1,"title":"Medprin Medical's Dural Sealant Product Enters Special Review Pathway for Innovative Medical Devices","media":"Stock News","content":"<p>Medprin Regenerative Medical Technologies Co.,Ltd. (301033.SZ) announced that its self-developed dural sealant product has recently been accepted by the Center for Medical Device Evaluation of the National Medical Products Administration to enter the special review program for innovative medical devices. The dural sealant is indicated for assisting in the closure of dural suture sites to prevent cerebrospinal fluid leakage. Based on an electrophile-nucleophile reaction mechanism, the product utilizes a globally leading patented technical formula and auxiliary accessories to achieve immediate and efficient sealing of dural suture sites during surgical procedures.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medprin Medical's Dural Sealant Product Enters Special Review Pathway for Innovative Medical Devices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedprin Medical's Dural Sealant Product Enters Special Review Pathway for Innovative Medical Devices\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-04-15 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Medprin Regenerative Medical Technologies Co.,Ltd. (301033.SZ) announced that its self-developed dural sealant product has recently been accepted by the Center for Medical Device Evaluation of the National Medical Products Administration to enter the special review program for innovative medical devices. The dural sealant is indicated for assisting in the closure of dural suture sites to prevent cerebrospinal fluid leakage. Based on an electrophile-nucleophile reaction mechanism, the product utilizes a globally leading patented technical formula and auxiliary accessories to achieve immediate and efficient sealing of dural suture sites during surgical procedures.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159883","symbol_name":"医疗器械","start_time":0,"source_url":"","article_id":"1194456333","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194456333","pubTimestamp":1776242912,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Medprin Regenerative Medical Technologies Co.,Ltd. (301033.SZ) announced that its self-developed dural sealant product has recently been accepted by the Center for Medical Device Evaluation of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","301033":"迈普医学","BK0251":"专用设备","BK1100":"医疗保健设备","09996":"沛嘉医疗-B","BK1222":"医疗保健用品","BK1574":"生物医药B类股","09997":"康基医疗","BK1583":"高瓴概念"},"translate_title":"Medprin Medical硬膜密封剂产品进入创新医疗器械特别审评路径","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"301033":1,"09996":1,"09997":1},"content_text":"Medprin Regenerative Medical Technologies Co.,Ltd. (301033.SZ) announced that its self-developed dural sealant product has recently been accepted by the Center for Medical Device Evaluation of the National Medical Products Administration to enter the special review program for innovative medical devices. The dural sealant is indicated for assisting in the closure of dural suture sites to prevent cerebrospinal fluid leakage. Based on an electrophile-nucleophile reaction mechanism, the product utilizes a globally leading patented technical formula and auxiliary accessories to achieve immediate and efficient sealing of dural suture sites during surgical procedures.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}